X
Company overview

ImmuneOnco Biopharmaceuticals (Shanghai) Co.,Ltd., founded in June 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early-stage biopharmaceutical company dedicated to development and commercialization of novel cancer immunotherapeutics that reverse cancer cell-induced immune inhibition and actively eradicate cancer cells.

See details
2Science & Technology
The company is mainly committed to the development and research of immunotherapy products for tumors. The researched and developed products include monoclonal antibodies against immunomodulatory targets and armed target-specific NK cells. immunomodulatory targets and armed target-specific NK cells
See details
Science & Technology
The company is mainly committed to the development and research of immunotherapy products for tumors. The researched and developed products include monoclonal antibodies against immunomodulatory targets and armed target-specific NK cells.
See details
News Center
Company
Company overview
Management Team
Board of Directors
Scientific advisers
Science
Platforms
Presentations
Publications
Pipeline
Pipeline
Collaboration
Collaboration
Inverstors&Publications
Investors
News
Company news
Contact us
Contact us
Copyright © 2020 ImmuneOnco All Rights Reserved Shanghai ICP Bei No.15048165
Technical Support：Zhaoyee